The call, on record
HIMS bullish call
Quoted text as recorded“This is a multi-trillion dollar industry that Himm and Hers is the disruptor that the aggregator of demand that is potentially a trillion dollar business long-term.”
Our interpretation
- Source published
- Aug 19, 2026
- Timeframe
- long-term
- Interpreted confidence
- low
- Specificity
- vague
Why this call is unscored
- Status
- Not scored
- Notes
- There is no numerical target that can be objectively scored.
Email me when HIMS calls resolve
When a tracked HIMS call is scored — hit, miss or partial — we’ll email you the result. No account needed.
Used only for these updates. Privacy
Our summary of the thesis
Strongly BullishStructured interpretation of the video, not a verbatim quotation. Check the source for conditions, emphasis and context.
Travis views Hims & Hers as his biggest portfolio position, citing reaccelerating revenue growth after the GLP-1 compounding loophole closed, a new Novo Nordisk partnership, and an expanding 'healthcare aggregator' business model. He believes the company has significant room for margin expansion and multiple re-rating given its low EV/sales.
Key arguments
- Revenue growth reaccelerated to 38% in Q2 2026 after slowing to 3.8% when the GLP-1 compounding loophole closed
- New agreement to sell Eli Lilly and Novo Nordisk branded GLP-1s repositions the weight-loss business
- Subscriber count jumped to 2.9 million, partly from the Eucalyptus acquisition, with spend per subscriber also rising
- Positioning as a healthcare 'aggregator' that captures user data and cross-sells more solutions
- Trading at just 2.8x EV/sales trailing and under 2x forward, with margins near breakeven and upside to expand
Counter-arguments acknowledged
- Stock is very volatile, down about 25% since early July highs near $40
- Still down almost 20% for the year despite the rally off February lows
Hedges and caveats (from the video)
- Stocks are volatile and subject to market fluctuations
- Portfolio performance is historical and not guaranteed to continue
- Video creator owns these stocks (potential conflict of interest)
- Regulatory changes can impact business models (e.g., FDA closure of GLP-1 loophole)
- Reliance on future revenue growth and margin expansion assumptions
About this record
Not yet reviewed by a moderatorAI-extracted record. A quote, summary and outcome each need their own context. Moderator review does not certify investment performance.
- Source published
- Aug 19, 2026, 7:26 PM UTC
- First recorded by TubeRank
- Aug 19, 2026, 8:20 PM UTC
- Record last updated
- Oct 6, 2026, 6:32 AM UTC
- Moderator review recorded
- Not recorded
- Transcript provenance
- YouTube captions (manual or automatic)
- Recorded analysis processor/source label
- claude-sonnet-5
- This can identify a workflow rather than an exact AI model version.
- Extraction pipeline version
- v1.0.0
- Outcome methodology version
- 2026-10-06.5
- Outcome reason code
- missing_target
Recent record changes 4 shown
Oct 6, 2026, 6:32 AM UTC
corrected
- Outcome methodology version
Before2026-10-06.4
After2026-10-06.5
Oct 6, 2026, 5:14 AM UTC
corrected
- Outcome methodology version
Before2026-10-06.2
After2026-10-06.4
Oct 6, 2026, 4:00 AM UTC
corrected
- Outcome methodology version
Before2026-10-06.1
After2026-10-06.2
Oct 6, 2026, 3:27 AM UTC
missing target
- Outcome methodology version
BeforeNot recorded
After2026-10-06.1
- Recorded outcome date
BeforeNot recorded
After2026-10-06
- Outcome explanation
BeforeNot recorded
AfterThere is no numerical target that can be objectively scored.
- Outcome reason
BeforeNot recorded
AfterMissing target
Showing up to 20 recent changes. The complete feed has 5 recorded events for this call, including its initial entry. Read the full paginated history (JSON); follow nextCursor while hasMore is true.
Stored outcome evidence
- Stored reference price
- Not recorded
- Not recorded · provider not recorded
- Target as extracted
- Not recorded
- Stated deadline as extracted
- None recorded
- Recorded outcome date
- Oct 6, 2026
- Outcome price observation
- Not recorded
- Not recorded · provider not recorded
Stored explanation
There is no numerical target that can be objectively scored.
Missing timestamps, providers and versions are historical gaps. Stored observations can include daily closes; they do not show every intraday touch or prove an executable trade. Read the methodology.
Why we interpreted the confidence this way
Uses hedge word 'potentially' and no specific timeframe, but is a clear directional long-term bull thesis on company value rather than a per-share price target.